Af­ter pos­i­tive pan­el vote, Sh­iono­gi an­tibi­ot­ic scores US ap­proval

Safe­ty con­cerns linked with Sh­iono­gi’s an­tibi­ot­ic were put to bed by an ex­pert pan­el to the FDA, who large­ly vot­ed to back the drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.